Agios on today’s phase 2 data for the pyruvate kinase activator mitapivat in sickle cell disease
Brian Goff, CEO of Agios Pharma, on today's phase 2 SCD data and how he thinks maitapivat can fit into the competitive landscape.
Also look for unique social pages for BiotechTV U.
Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium rental lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.